Patents Assigned to Cell Pathway and the University of Arizona
  • Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes for neoplasia
    Patent number: 6426349
    Abstract: Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes are useful for inducing or promoting apotosis and for arresting uncontrolled neoplastic cell proliferation, and are specifically useful in the arresting and treatment of neoplasias, including precancerous and cancerous lesions.
    Type: Grant
    Filed: December 20, 2000
    Date of Patent: July 30, 2002
    Assignee: Cell Pathway and the University of Arizona
    Inventors: Gerhard J. Sperl, Paul Gross, Klaus Brendel, Gary A. Piazza, Rifat Pamukeu